WEBARIKAYCE Prescription and Arikares® Support Program Enrollment Form Fax: 1-800-604-6027 or E-mail: enrollment@arikares.com . Please complete all ields on pages 1 and 3 to prevent any delays and include scanned copies of both sides of the patient’s insurance card (ields marked with an asterisk [*] are mandatory/required). Questions? Phone: 1 ...
Prescribing ARIKAYCE (amikacin liposome inhalation suspension)
WEBTo prescribe ARIKAYCE, first complete the Arikares ® Enrollment Form with your patients. The Arikares Enrollment Form allows you to both prescribe ARIKAYCE and enroll your patients in the Arikares Support Program. A patient's signature on the Enrollment Form gives them access to support services.
WEBArikares Support Program Enrollment Form and Prescription (Rx) (First Shipment Includes Lamira® System) To get started, submit all pages of this form through Fax: 1-800-604-6027 or E-mail: enrollment@arikares.com Please complete all fields on page 1 and 3 to prevent any delays and include scanned copies of both sides of your insurance card
Resources for HCPs - ARIKAYCE
WEBArikares Enrollment Form. To prescribe ARIKAYCE, this form must be completed. Patient signature is required for enrollment in Arikares. Submit via fax (1-800-604-6027) or email (enrollment@arikares.com).
MAC Support | ARIKAYCE® (amikacin liposome inhalation …
WEBDownload and print the Arikares Enrollment Form and complete it with your doctor at your next appointment. English Patient Support Program Enrollment Consent detailed information: Insmed data processors, affiliates, and the following third parties include PANTHERx RARE Pharmacy, Maxor National Pharmacy Services LLC, CMIC Inizio CO …
WEBPROGRAM ENROLLMENT • Complete the Arikares Enrollment Form enclosed or download an interactive form by visiting ArikaresEnrollmentForm.com - Submit all pages via fax (1-800-604-6027) or e-mail (enrollment@arikares.com) PAYER ACCESS EDUCATION • Patient Access Lead (PAL) is available to provide the most recent publicly available
FDA approves a new antibacterial drug to treat a serious lung …
WEBThe U.S. Food and Drug Administration today approved a new drug, Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of bacteria,...
WEBEnrollment Form Fax: 1-800-604-6027 or E-mail: enrollment@arikares.com Please complete all fields on pages 1 and 3 to prevent any delays and include scanned copies of both sides of the patient’s insurance card (fields marked with an asterisk [*] are mandatory/required). Questions? Phone: 1-833-ARIKARE (1-833-274-5273) Alternate …
WEBThe recommended dosage of ARIKAYCE in adults is once daily inhalation of the contents of one 590 mg/8.4 mL ARIKAYCE vial (590 mg of amikacin) using the Lamira Nebulizer System. Administer ARIKAYCE with the Lamira Nebulizer System only. ARIKAYCE should be at room temperature before use.
Support Sign-up | ARIKAYCE® (amikacin liposome inhalation …
WEBSign up to receive support, resources, and financial assistance for your ARIKAYCE® treatment journey. See Prescribing & Safety Information, including Boxed Warnings.
- Some results have been removed
Skip to content